Compare BX & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BX | MDT |
|---|---|---|
| Founded | 1985 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.4B | 125.3B |
| IPO Year | 2007 | N/A |
| Metric | BX | MDT |
|---|---|---|
| Price | $142.59 | $102.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 19 |
| Target Price | ★ $176.80 | $109.63 |
| AVG Volume (30 Days) | 4.0M | ★ 7.7M |
| Earning Date | 01-29-2026 | 02-17-2026 |
| Dividend Yield | ★ 3.33% | 2.76% |
| EPS Growth | 6.91 | ★ 12.98 |
| EPS | ★ 3.87 | 3.69 |
| Revenue | $14,212,824,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $15.71 | $8.63 |
| Revenue Next Year | $21.97 | $5.84 |
| P/E Ratio | $36.80 | ★ $27.90 |
| Revenue Growth | ★ 12.24 | 5.34 |
| 52 Week Low | $115.66 | $79.55 |
| 52 Week High | $190.09 | $106.33 |
| Indicator | BX | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 34.37 | 65.28 |
| Support Level | $147.96 | $99.69 |
| Resistance Level | $149.65 | $102.10 |
| Average True Range (ATR) | 4.44 | 1.96 |
| MACD | -1.86 | 0.40 |
| Stochastic Oscillator | 11.27 | 98.55 |
Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.